4//SEC Filing
Balcom Alexandra 4
Accession 0001193125-25-314301
CIK 0001861560other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:30 PM ET
Size
6.7 KB
Accession
0001193125-25-314301
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Balcom Alexandra
Chief Financial Officer
Transactions
- Sale
Class A Common Stock
2025-12-08$110.31/sh−6,984$770,405→ 54,750 total - Sale
Class A Common Stock
2025-12-08$111.32/sh−100$11,132→ 54,650 total
Footnotes (3)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.98, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.22 to $111.42, inclusive.
Documents
Issuer
Nuvalent, Inc.
CIK 0001861560
Entity typeother
Related Parties
1- filerCIK 0001862147
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 4:30 PM ET
- Size
- 6.7 KB